SecBot SecBot

KZR

Kezar Life Sciences, Inc.
Nasdaq· Pharmaceutical Preparations· Inc. DE· CIK 0001645666 Biotech & Drug Discovery
No price
Median target
$6.00
range $5.00–7.00
Short interest
158.5K
+4.6%
Days to cover
2.3
at average volume
Insider net
$0
no open-market trades · since May 11
New fund stakes
0
Q1 2026 13F · 0 exits
Filing reports
3
analyzed by SecBot
SecBot read BEARISH 3 reports · latest
Balance 1 bearish · 0 bullish · 2 neutral oldest → newest, height = score
Avg score ·High conf. 3/3

Price

Daily candles with volume.

Signal stack

Where each data set points today.

  • InsidersNO TRADES

    No open-market buys or sells since May 11. Recent filings are awards, exercises and tax withholding.

  • InstitutionsMIXED

    Q1 2026: 2 added (0 new), 1 trimmed or exited.

  • EstimatesRISING

    Current-quarter EPS estimate −$1.255 → −$0.910 over 90 days. 1 up, 0 down in 30 days.

  • Short sellersSTEADY

    Short interest +4.6% to 158.5K shares. 2.3 days to cover.

Who's buying

13F· Q1 2026
0
new positions
0
exits
FundMoveSharesValue
RENAISSANCE TECHNOLOGIES LLCADD188,426$1.4M
FMR LLCDOUBLED10,208$75.7K
UBS Group AGTRIM13$96.00
VANGUARD GROUP INCADD341,404$2.1M
STATE STREET CORPADD27,093$170.4K
TWO SIGMA INVESTMENTS, LPTRIM11,312$71.2K
MORGAN STANLEYTRIM5,685$35.8K
FMR LLCNEAR_EXIT208$1.3K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

Last action Oct 2025
Recent actions
DateFirmActionRating
Oct 17, 2025Jefferies
DOWNGRADE
DOWNGRADEHold
Oct 17, 2025William Blair
DOWNGRADE
DOWNGRADEMarket Perform
Oct 17, 2025Wells Fargo
MAINTAIN
MAINTAINEqual-Weight
Jul 16, 2025HC Wainwright & Co.
REITERATE
REITERATENeutral
Dec 19, 2024Wells Fargo
MAINTAIN
MAINTAINEqual-Weight
Dec 2, 2024HC Wainwright & Co.
REITERATE
REITERATENeutral

Insider ledger

Form 4
$0
open-market buys or sells · since May 11
DateInsiderTypeValue
May 11, 2026
Chiang Pichi Luo
SVP, Corporate Controller
May 11, 2026
TO ISSUER7,999 sh
May 11, 2026
Chiang Pichi Luo
SVP, Corporate Controller
May 11, 2026
TO ISSUER4,999 sh
May 11, 2026
Chiang Pichi Luo
SVP, Corporate Controller
May 11, 2026
TO ISSUER2,899 sh
May 11, 2026
Chiang Pichi Luo
SVP, Corporate Controller
May 11, 2026
TO ISSUER2,499 sh
May 11, 2026
Chiang Pichi Luo
SVP, Corporate Controller
May 11, 2026
TO ISSUER2,401 sh
May 11, 2026
Chiang Pichi Luo
SVP, Corporate Controller
May 11, 2026
TO ISSUER599 sh
May 11, 2026
Chiang Pichi Luo
SVP, Corporate Controller
May 11, 2026
TO ISSUER2,052 sh
May 11, 2026
Chiang Pichi Luo
SVP, Corporate Controller
May 11, 2026
TO ISSUER1,199 sh

Earnings setup

Estimates
−$0.91
EPS estimate, this quarter
+27%
estimate change, 90 days
1↑ 0↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Next FY-$3.96-$4.66–-$3.27-28.5%$0.00
Current Q-$0.91-$0.91–-$0.91+27.5%$0.00
Current FY-$4.02-$4.46–-$3.58-22.9%$0.00
Next Q-$0.87-$0.87–-$0.87+29.6%$0.00

Short side

FINRA· Apr 30, 2026
158,519
shares short
+4.6%
vs prior settlement
2.3
days to cover
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Aug 11, 2026 Earnings calendar
KZR Q2 2026 Earnings Scheduled, 2026-08-11
May 15, 2026 SEC
Kezar Life Sciences' registration statement on Form S-3 (File No. 333-284712) was declared effective by the SEC on May…
EFFECT · Impact 5/10
May 11, 2026 SEC
Nasdaq filed a 25-NSE notification to remove Kezar Life Sciences' common stock from listing, effective immediately…
25-NSE · Impact 2/10
May 11, 2026 SEC
Kezar Life Sciences has been acquired by Aurinia Pharma U.S., Inc. in a completed tender offer and merger…
8-K · Impact 8/10
May 11, 2026 Insider
Chiang Pichi Luo disposed of 7,999 shares
SVP, Corporate Controller
May 11, 2026 Insider
Chiang Pichi Luo disposed of 4,999 shares
SVP, Corporate Controller
May 11, 2026 Insider
Chiang Pichi Luo disposed of 2,899 shares
SVP, Corporate Controller
Mar 31, 2026 Inst.
RENAISSANCE TECHNOLOGIES LLC · ADD
188,426 shares ($1.4M)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent

SecBot reports

3 filings · 0 bullish · 1 bearish · 2 neutral
All KZR filing & press-release reports (3)